Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Acne mRNA vaccine

PreclinicalVaccine

Acne mRNA vaccine is one of 31 biologic programs targeting Acne. It is currently in Preclinical.

1

Indications

2

Total Trials

2

Active Trials

30

Competitors

Pipeline

Status by Indication[3][1]

Indication

AcneRecruiting

AcnePreclinical

Recruiting

Competition

Competitive Landscape

30 competitors in Acne

#DrugCompanyPhaseTrials

Accutane

CConrado Roberto Hoffmann Filho

Rogaine

Epidiolex

Jazz Pharmaceuticals

Acanya

Niacor

Medrol

Otezla

Folvite

Aldactone

Vibramycin

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2028

Phase 1/2Recruiting

Immunogenicity

NCT06316297

Q1 2030

PreclinicalRecruiting

Acne

NCT07013747

Clinical

Trials by Indication[1]

Immunogenicity1 trial

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

Recruiting· Sanofi logo

Sanofi·Phase 1/2·NCT06316297·260 enrolled

Acne1 trial

A Phase 1/2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Participants With Mild Acne

Recruiting· Sanofi logo

Sanofi·Preclinical·NCT07013747·228 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Acne mRNA vaccine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Acne mRNA vaccine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Acne mRNA vaccine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sanofi company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Vaccine[2]
Highest Phase: Preclinical[1]
Company: Sanofi

Related News